Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Aurora Cannabis (ACB) Stock: The Real Story With This Earnings Report

By InvestorPlace Research Staff
Aurora Cannabis (ACB) dropped roughly 9.5% today on last night’s quarterly results. But there’s a lot more to this story behind the headlines – and a major upside catalyst on the horizon. So let’s take a look.

Expect Cronos Stock to Fall as Losses Widen

By Mark R. Hake, CFA
Cronos management announced that EBITDA losses will likely widen in the second half of the year. Investors will see CRON stock fall further.

Weak Earnings Might Cause Aurora Cannabis Stock to Keep Falling

By Thomas Niel, InvestorPlace Contributor
An earnings disappointment calls into question the valuation of Aurora Cannabis stock. Investors should continue to avoid ACB stock.

As Canadians Get Ready for Edibles, is Hexo Stock Ready to Bounce?

By Theodore Kim
Hexo stock is well-poised to benefit from the next stage of cannabis legalization north of border. Gummies and drinks could fuel HEXO gains.

New Cannabis Research Will Be Bittersweet for Tilray Stock

By Mark Putrino, CMT
Important news from the U.S. Drug Enforcement Administration will be bittersweet for Tilray stock and its cannabis peers.

Why the Future of Canopy Growth Stock Is in the Hands of the President

By Will Ashworth, InvestorPlace Contributor
President Trump recently made positive comments about federally legalized cannabis. That’s good news for Canopy Growth and CGC stock.

New Deals in Europe Could Boost Tilray Stock

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
After missing analyst estimates on profit loss, a new shipping agreement could be just what Tilray stock needs to soar high again.

Aurora Cannabis Needs to Keep its Finger on the Marijuana Pulse

By Todd Shriber, InvestorPlace Contributor
Aurora Cannabis has a viable story, but it could cement its long-term growth by entering the U.S. marijuana market.

CGC Stock Very Well May Be Trading Sideways for Awhile

By Mark Putrino, CMT
Despite some positive developments Canopy Growth Corporation continues to disappoint shareholders as CGC stock trends lower.

Cronos Group’s Deal with Altria Presents ESG Concerns for CRON Stock

By Mark Putrino, CMT
Cronos Group stock may not be attractive to institutions with ESG concerns. That is because its deal with Altria makes it a sin stock.

Can Aurora Cannabis Sales Overcome the Black Market?

By Mark Putrino, CMT
Are the sales of Aurora Cannabis and other cannabis growers being affected by the black market? I think so ... here's why.

Is Aurora Cannabis Stock the Top Pot Play?

By Brad Moon, InvestorPlace Contributor
With ACB stock nearing 2019 lows and Q4 earnings due in two weeks, is now the time to add Aurora Cannabis to your portfolio?

Marijuana Stocks: One Chart Says Now Is The Time to Buy

By InvestorPlace Research Staff
Don’t get caught in the herd of doubters running for the hills. The long-term story for marijuana stocks is intact, and today is the day to buy.

Hexo Stock Smokes its Competition

By Chris Markoch, InvestorPlace Contributor
In an emerging industry like cannabis, when one stock drops, they all drop. But a look at Hexo shows not all cannabis companies are the same.

Hexo Stock Drops as the Company Continues to Lose Money

By Mark Putrino, CMT
HEXO stock has dropped by 50% in just four months. Investors are now coming to terms with the fact that the company is losing money.

Should Investors Buy Aurora Cannabis Stock At Current Levels?

By Tezcan Gecgil, InvestorPlace Contributor
The cannabis industry's fundamentals do not fully support ACB's stock's high valuation.

What Investors Should Know From Cronos Stock’s Earnings Release

By Mark Putrino, CMT
CRON stock just released its second-quarter earnings and the price of CRON stock has trended lower since then.

Canopy Growth Stock Is Short on Fundamentals, But High on Potential

By Josh Enomoto, InvestorPlace Contributor
The markets have punished Canopy Growth stock for pinging red flags on fundamental metrics like goodwill. However, this emphasis misses the point that CGC currently runs not on fundamentals but on narratives.

When Exactly Will Aurora Cannabis Stock’s Downtrend End?

By Chris Lau, InvestorPlace Contributor
Disappointing earnings from CannTrust Holdings and regulatory violations from Tilray hurt Aurora Cannabis stock. Investors must decide if it's time to buy or hold on this dip.
Load More